Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis: Preliminary results

Journal of Neurology

Volumn 251, Issue 10, 2004, Pages 1215-1219

  Airla, Nina ^a   Luomala, Mari ^a   Elovaara, Irina ^a,c   Kettunen, Eeva ^a   Knuutila, Sakari ^b   Lehtimäki, Terho ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Gene expression; Immunological activation; Intravenous methylprednisolone; Multiple sclerosis; Relapse

Indexed keywords

CD5 ANTIGEN; COMPLEMENTARY DNA; GLYCOPROTEIN; MESSENGER RNA; METHYLPREDNISOLONE; NEUROTOXIN; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DNA MICROARRAY; FEMALE; GENE REPRESSION; GENE TARGETING; HUMAN; IMMUNE RESPONSE GENE; LYMPHOCYTE DIFFERENTIATION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RELAPSE; RNA ISOLATION; T LYMPHOCYTE ACTIVATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD5; DNA-BINDING PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-TYROSINE KINASES; RNA; TRANSCRIPTION FACTORS;

EID: 8744256370     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0516-y     Document Type: Article

References (22)

1. Aalto Y, El-Rifa W, Vilpo L, Ollila J, Nagy B, Vihinen M, Vilpo J, Knuutila S (2001) Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 15:1721-1728
2. Andersson PB, Goodkin DE (1998) Glucocorticosteroid therapy for multiple sclerosis: a critical review. J Neurol Sci 160:16-25
3. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL (1987) Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 236:77-81
4. Debierre-Grockiego F, Desaint C, Fuentes V, Poussin M, Socie G, Azzouz N, Schwarz RT, Prin L, Gouilleux-Gruart V (2003) Evidence for glycosylphosphatidylinositol (GPI)-anchored eosinophil-derived neurotoxin (EDN) on human granulocytes. FEBS Lett 537:111-116
5. Droogan AG, Crockard AD, McMillan SA, Hawkins SA (1998) Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS. Neurology 50:224-229
6. Elovaara I, Lalla M, Spare E, Lehtimaki T, Dastidar P (1998) Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS. Neurology 51:1703-1708
7. Gallo P, Chiusole M, Sanzari M, Sivieri S, Piccinno MG, Argentiero V, Rizzotti P, Tavolato B (1994) Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. Acta Neurol Scand 89:95-101
8. Gayo A, Mozo L, Suarez A, Tunon A, Lahoz C, Gutierrez C (1998) Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. J Neuroimmunol 85:122-130. DOI:10.1016/S0165-5728(97)00262-2
9. Gelati M, Corsini E, De Rossi M, Masini L, Bernardi G, Massa G, Boiardi A, Salmaggi A (2002) Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis. Arch Neurol 59:774-780
10. Gold R, Buttgereit F, Toyka KV (2001) Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117:1-8
11. Hardy RR (1989) B cell ontogeny and B cell subsets. Curr Opin Immunol 2:189-198
12. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T (1987) Rheumatoid factor secretion from human Leu-1+ B cells. Science 236:81-83
13. Hemmer B, Archelos JJ, Hartung HP (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3:291-301. DOI:10.1038/nrm784
14. Kuo CT, Leiden JM (1999) Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 17:149-187
15. Marie I, Durbin JE, Levy DE (1998) Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 17:6660-6669
16. Mix E, Olsson T, Correale J, Baig S, Kostulas V, Olsson O, Link H (1990) B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 79:21-27
17. Ramanathan M, Weinstock-Guttman B, Nguyen LT, Badgett D, Miller C, Patrick K, Brownscheidle C, Jacobs L (2001) In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol 116:213-219
18. Rosenberg HF, Domachowske JB (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70:691-698
19. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N (1998) Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441:106-110
20. Steinman L (2001) Multiple sclerosis: a two-stage disease. Nat Immunol 2:762-764
21. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, van de Wetering M, Oosterwegel M, Wilson A, MacDonald HR, Clevers H (1995) An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374:70-74
22. Zhang X, Moilanen E, Adcock IM, Lindsay MA, Kankaanranta H (2002) Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci 71:1523-1534